GMAB compared with DEO: revenue, margins and what each company keeps, and the suppliers and customers both name

GMABGenmab A/S

Mkt capRevenueRevenue

DEODiageo PLC

Mkt capRevenueRevenue

Compare

GMABGenmab A/S

DEODiageo PLC

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

GMAB: latest quarter not drawable. DEO: latest quarter not drawable.Method ›

Price

rebased to 0%

GMAB, solidDEO, dashed

GMABGenmab A/S

57.03▲+0.96%· post 57.15

Mkt cap$36.7B

DEODiageo PLC

93.45▲+2.32%· post 93.39

ClosedOct 30 '26

Mkt cap$56.8B

Compare

ClosedOct 30 '26

GMABGenmab A/S

DEODiageo PLC

57.03▲+0.96%post 57.15

Price

93.45▲+2.32%post 93.39

$36.7B

Mkt cap

$56.8B

GMAB57.03▲+0.96%vsDEO93.45▲+2.32%ClosedOct 30 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only GMAB 1

COAGHemab Therapeuticscustomer

Shared 0

No shared counterparties.

Only DEO 1

JJacobs Solutionssupplier

Role chip = supplier or customerSource: SEC EDGAR